login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
QUANTERIX CORP (QTRX) Stock News
NASDAQ:QTRX -
US74766Q1013
-
Common Stock
4.855
USD
+0.02 (+0.31%)
Last: 8/22/2025, 3:55:05 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
QTRX Latest News, Press Relases and Analysis
All
Press Releases
a day ago - By: Quanterix Corporation
Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit
10 days ago - By: Zacks Investment Research
Down 24.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Quanterix (QTRX)
11 days ago - By: Quanterix Corporation
Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference
15 days ago - By: Benzinga
- Mentions:
GSAT
PGY
ADV
REAL
...
Earnings Scheduled For August 7, 2025
16 days ago - By: Benzinga
Earnings Preview: Quanterix
15 days ago - By: Zacks Investment Research
- Mentions:
CAPR
Quanterix Corporation (QTRX) Reports Q2 Loss, Misses Revenue Estimates
15 days ago - By: Quanterix Corporation
Quanterix Releases Financial Results for the Second Quarter of 2025
18 days ago - By: Quanterix Corporation
Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025
18 days ago - By: Quanterix Corporation
Quanterix Announces Cooperation Agreement with Kent Lake Capital
25 days ago - By: Quanterix Corporation
Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC
a month ago - By: Quanterix Corporation
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 months ago - By: Quanterix Corporation
Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum
2 months ago - By: Quanterix Corporation
Quanterix Expands Reach with IVD and Large Reference Labs
3 months ago - By: Quanterix Corporation
Quanterix to Present at Goldman Sachs Global Healthcare Conference
3 months ago - By: Kent Lake PR LLC
- Mentions:
AKYA
Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal
3 months ago - By: Zacks Investment Research
- Mentions:
MDT
Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates
3 months ago - By: Quanterix Corporation
Quanterix Releases Financial Results for the First Quarter of 2025
4 months ago - By: Zacks Investment Research
- Mentions:
PAHC
Phibro Animal Health (PAHC) Q3 Earnings Beat Estimates
4 months ago - By: Quanterix Corporation
Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025
4 months ago - By: Kent Lake PR LLC
Kent Lake Issues Statement on Quanterix’s Blatant Disregard for Will of Shareholders
4 months ago - By: Quanterix Corporation
- Mentions:
AKYA
Quanterix and Akoya Biosciences Announce Amended Merger Agreement
4 months ago - By: Halper Sadeh LLC
- Mentions:
BRDG
AKYA
CKPT
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AKYA, CKPT, QTRX on Behalf of Shareholders
4 months ago - By: Kent Lake PR LLC
Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders
5 months ago - By: Kent Lake PR LLC
Kent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled Akoya
5 months ago - By: Quanterix Corporation
Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit
5 months ago - By: Quanterix Corporation
Quanterix Releases Financial Results for the Fourth Quarter of 2024
5 months ago - By: Kent Lake PR LLC
Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today’s Earnings Call
Please enable JavaScript to continue using this application.